Olema Pharmaceuticals faced a 30% stock drop after ESMO 2025 data on palazestrant, its lead breast cancer candidate. Click ...

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...

Commission approves acquisition of JB Chemicals & Pharmaceuticals Ltd by Torrent Pharmaceuticals Ltd with voluntary ...

It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger.

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

From Ramesh Damani to Atul Suri; Dipan Mehta to Nilesh Shah; Dharmesh Kant to Deven Choksey, here's what these market experts ...

​This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this ...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 3 ...

Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.

Stocks rose to begin a busy week that will see a flurry of corporate earnings reports, with investors also awaiting further ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...